StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.57−0.13 (-3.51%)

Close on Nov 18, 2026Market cap $99.44MP/E –Yield –

Unicycive Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Unicycive Therapeutics's market cap was $105.29M on Nov 11, 2026, against $134.90M a year earlier. Over the last 5 years it ranged from $7.87M to $186.25M, with a median of $33.02M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$105.29M-12.5%
2025Dec 31, 2025$120.31M+54.8%
2024Dec 31, 2024$77.72M+157.7%
2023Dec 29, 2023$30.16M+270.1%
2022Dec 30, 2022$8.15M-73.6%
2021Dec 31, 2021$30.84M–

More Unicycive Therapeutics figures

See a number that looks wrong?